Effect of anti-rheumatic drugs on the clinical outcome of autoimmune rheumatic diseases patients infected with COVID-19: A systemic review and meta-analysis
Qin-Yi Su1,2,3#, Sheng-Xiao Zhang1,2,3#, Jing Luo1,2,3, Ting Cheng1,2,3, He-Yi Zhang2,3, Yan Zhang2,3, Bing-Ru Zhao2,3, Chong Gao4, Cai-Hong Wang1,2,3*
1 Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China. 2 Shanxi Provincial Key Laboratory of Rheumatism Immune Microecology, Taiyuan, Shanxi, China. 3 Key Laboratory of Cellular Physiology at Shanxi Medical University, Ministry of Education, Taiyuan, China. 4Brigham and Women’s Hospital, Harvard Medical School, Department of Pathology, Boston, United States of America
#Qin-Yi Su and Sheng-Xiao Zhang contributed to the work equally and should be regarded as co-first authors.
* Cai-Hong Wang is corresponding authors.
*Cai-Hong Wang: Phone number: +8613603515399; E-mail address: snwch@sina.com;Present address: 382, Wuyi Road, Taiyuan, Shanxi